First trimester screening for aneuploidy: Serum biochemical markers
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Seminars in Perinatology
- Vol. 23 (5), 359-368
- https://doi.org/10.1016/s0146-0005(99)80002-0
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Antenatal Screening for Down's SyndromeJournal of Medical Screening, 1997
- Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndromePrenatal Diagnosis, 1997
- Maternal serum screening for Down syndrome in the United States: A 1995 surveyAmerican Journal of Obstetrics and Gynecology, 1997
- PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKERPrenatal Diagnosis, 1996
- Serum PAPP‐A measurements in first‐trimester screening for Down syndromePrenatal Diagnosis, 1993
- Supported in part by grant No. HD04612 to the Mental Retardation Research Center. Presented at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 1118, 1992.American Journal of Obstetrics and Gynecology, 1993
- Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotypeBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome.BMJ, 1992
- FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROMEThe Lancet, 1988
- FETAL CHROMOSOMAL ANEUPLOIDIES AND MATERNAL SERUM ALPHA-FETOPROTEIN LEVELS IN FIRST TRIMESTERThe Lancet, 1986